Zelira Therapeutics Ltd

ZLD

Company Profile

  • Business description

    Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema, and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.

  • Contact

    101 St George’s Terrace
    Level 3
    PerthWA6000
    AUS

    T: +61 865580886

    https://www.zeliratx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    8

Stocks News & Analysis

stocks

3 cheap fully franked stocks

Well priced Aussie shares that offer a tax rebate.
stocks

Are investors too bearish on Australian equities?

A new report suggests the pessimism might be overdone.
stocks

What is going wrong and right at CSL

Shares plunge after guidance is cut.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,178.905.000.05%
CAC 408,157.2943.59-0.53%
DAX 4024,118.895.32-0.02%
Dow JONES (US)47,522.12109.88-0.23%
FTSE 1009,760.063.920.04%
HKSE26,282.6963.45-0.24%
NASDAQ23,581.14377.33-1.57%
Nikkei 22551,325.6117.960.04%
NZX 50 Index13,459.2950.080.37%
S&P 5006,822.3468.25-0.99%
S&P/ASX 2008,885.505.500.06%
SSE Composite Index3,986.9029.43-0.73%

Market Movers